CMAT Advantage Roadmap—What Physicians Can Expect in 2025 and Beyond

ByJack

1 | Why Publish a Forward Roadmap Now?

  • Stricter screening guidance – The 2024 ACC/AHA PAD guideline urges wider use of automated ABI + PVR in high-risk adults. acc.org
  • AI regulation is maturing – FDA released draft lifecycle guidance for AI-enabled device software in 2025. fda.gov
  • Reimbursement is shifting – New Remote Patient Monitoring (RPM) codes (99453, 99454, 99457) give clinics another billing on-ramp for physiologic data. thoroughcare.net

To keep your clinic future-proof, HealthWright Technologies Inc is publishing its multi-year CMAT Advantage roadmap so you can align capital planning and workflow design well ahead of time.

2 | Roadmap at a Glance

Release WindowCode NameKey Physician Benefits
2025 · Q3v5.4 “Cassini”AI-driven PAD risk scores, central-aortic-pressure (CAP) algorithm, single-tap FHIR® export
2025 · Q4CMAT-RPM LitePassive data upload for CPT 99453/99454 billing; automatic clinician-time tracker for 99457
2026 · H1v6.0 “Atlas” (major)12-lead surrogate module, Bluetooth® home-ankle cuff pairing, zero-trust cybersecurity stack
2026 · H2Data-Hub 2.0Multi-site analytics dashboard, bulk quality-measure export (MIPS, ACO REACH)
2027 · 2028“Nova” SeriesCloud-based predictive analytics, patient-facing portal, tele-expert referral API

(Timing reflects current targets; functionality may shift pending FDA clearance and payer rule-making.)

3 | Near-Term (2025) Enhancements in Detail

3.1 v5.4 “Cassini” (ETA September 2025)

UpgradeWhat It Means in Clinic
AI PAD-Risk IndexReal-time score that stratifies asymptomatic PAD likelihood, calibrated to FDA January 2025 AI guidance. fda.gov
Central Aortic Pressure (CAP)CPT cross-walk to 93050 (pending) gives another reimbursable metric without extra cuffs.
FHIR 4.0 PushOne-click export to major EHRs (Epic, Athena, eClinicalWorks) for friction-free documentation.

Why it matters: AI scoring helps satisfy guideline calls for “earlier functional PAD detection.” acc.org

3.2 CMAT-RPM Lite (ETA December 2025)

  • At-Home Cuff Kit: Patients perform simplified ankle-brachial measurements; data sync nightly.
  • Automatic Time Tracking: On-platform stopwatch logs > 20 min interactive time for CPT 99457. ♪thoroughcare.net
  • Alert Rules Engine: Flags rapid ankle-pressure drops or HRV shifts for same-day callbacks.

4 | Medium-Term (2026) Milestones

FeaturePhysician Impact
v6.0 “Atlas”• Surrogate 12-lead (3-wire VCG) overlays PAD & ANS findings for holistic cardio-metabolic view.• Home-ankle cuff pairs via Bluetooth to reduce in-office repeat testing.• Zero-trust security meets evolving FDA cybersecurity pre-market guidance.
Data-Hub 2.0• Multi-location benchmarking—see which site is leaving CPT dollars unclaimed.• Bulk export for MIPS CQM #418 (screening for psychosocial risk), PAD quality metrics.

5 | Long-Term Vision (2027 – 2028)

  1. Predictive Analytics “Nova” Platform
    • Uses de-identified cross-practice datasets to forecast 12-month PAD progression.
    • Offers pay-for-performance dashboards for VBC contracts.
  2. Patient Portal & Tele-Expert API
    • Patients access color-coded trends; can forward to vascular specialists.
    • Clinics bill interprofessional e-consult CPT 99451 without new hardware.
  3. Expandable Sensor Bus
    • Hardware headroom to snap-in photoplethysmography (PPG) finger sensors or skin-temperature probes as reimbursement pathways mature.

6 | Compliance & Regulatory Alignment

Rule / Draft GuidanceRoadmap Alignment
FDA AI-Enabled Device Lifecycle Draft (Jan 2025)Adopts pre-determined change-control plan (PCCP) for AI modules starting v5.4. fda.gov
CY 2025 Physician Fee ScheduleDespite a 2.93 % overall cut, triple-CPT + RPM pathways shield ancillary revenue. cms.govcms.gov
HIPAA & Zero-Trustv6.0 will ship with device-level encryption and token-based API calls to satisfy updated ONC info-blocking rules.

7 | What Physicians Should Do Now

Next 90 DaysQ4 2025 Planning2026 Budget Cycle
• Verify your CMAT device is on firmware ≥ v5.3.1.• Enroll staff in 90-min MA certification (free).• Identify 25 high-risk PAD patients for RPM pilot.• Update EHR interface to accept FHIR Observation resources.• Allocate capital (or Section 179) for optional CAP sensor.• Add analytics subscription line-item (~$79/device/mo.)

8 | Key Take-Aways

  • Guideline-Ready: Roadmap aligns with ACC/AHA calls for earlier PAD detection and comprehensive autonomic assessment. acc.org
  • Revenue Resilience: Triple-CPT + RPM codes diversify income ahead of 2025 fee-schedule cuts. thoroughcare.netcms.gov
  • AI Future-Proofing: Planned AI modules follow FDA draft lifecycle guidance, ensuring smooth clearance pathways. fda.gov

Interoperability First: FHIR® 4.0 and zero-trust APIs keep data flowing—and auditors happy.

Similar Posts

TM-Flow System and Diabetic Neuropathy – Early Detection Strategies

ByJack

Detecting Diabetic Neuropathy Early with the TM-Flow System Diabetic neuropathy affects up to 50 percent of long-term diabetes patients and often begins with subtle nerve damage before overt symptoms appear. Small-fiber neuropathy—affecting pain and temperature fibers—is particularly difficult to detect with traditional methods. The TM-Flow System offers a non-invasive, objective way to measure these early…

Introduction to the TM-Flow System

ByJack

Why vascular & autonomic screening matter for modern practice In today’s medical landscape, the ability to detect early vascular and autonomic nervous system dysfunction can significantly impact patient outcomes and practice growth. The TM-Flow System offers a timely, in-office diagnostic solution that lets physicians screen for key markers such as peripheral arterial disease (PAD), autonomic…

The Business Case for Physicians: Adding CMAT™ TM-Flow Testing to Independent Clinics

ByJack

1 | Why Expand Beyond Traditional PAD Screening? CMAT™ TM-Flow, distributed by HealthWright Technologies Inc, addresses all three by delivering three billable diagnostics—ABI + PVR, autonomic nervous-system (ANS) analysis, and sudomotor testing—in a single 7- to 10-minute session. 2 | Clinical & Operational Advantages of the CMAT Device Dimension Traditional Doppler ABI CMAT Advantage /…

Medical Device Purchasing 101: Leveraging HealthWright Technologies’ CMAT Advantage

ByJack

1. Why a Strategic Buying Process Matters Value-based care, shrinking reimbursements, and tight capital budgets require proof that every device improves outcomes and the bottom line. HealthWright Technologies Inc positions the CMAT Advantage as a partnership, bundling FDA-cleared hardware with onboarding, clinical training, and ongoing technical support to help physicians integrate advanced diagnostics into their…

Five Common Diagnostic Device Pitfalls—And How CMAT Advantage Helps Physicians Avoid Them

ByJack

Introduction Even well-intended diagnostic purchases can under-deliver when they clash with day-to-day clinical realities—think inconsistent results, stalled workflows, or reimbursement headaches. Drawing on thousands of support tickets and field implementations, HealthWright Technologies Inc has identified five pitfalls that routinely reduce clinical effectiveness. Here’s how the CMAT Advantage—our flagship CMAT device for PAD, autonomic-nerve, and sudomotor…

CMAT Advantage vs Standard ABI Testing: What Independent Physicians Need to Know in 2026

ByJack

Published April 6, 2026 | HealthWright Technologies, Watkinsville, GA | For independent physicians Medical disclaimer: This article is intended for licensed healthcare professionals. Clinical decisions should always be based on individual patient evaluation and current medical guidelines. HealthWright Technologies is a Georgia-based medical device company and does not provide clinical advice. CMAT Advantage is HealthWright…